Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Tandem Diabetes Care | TNDM | Oct 31, 2024 | 31.37 | -3.06 |
Tanger | SKT | Oct 31, 2024 | 33.23 | -2.18 |
Tango Therapeutics | TNGX | Oct 31, 2024 | 5.43 | -4.82 |
Tantech | TANH | Oct 31, 2024 | 0.14 | -12.31 |
Taoping | TAOP | Oct 31, 2024 | 0.42 | -3.03 |
Tapestry | TPR | Oct 31, 2024 | 47.45 | -1.96 |
Targa Resources | TRGP | Oct 31, 2024 | 166.96 | +0.20 |
Target | TGT | Oct 31, 2024 | 150.04 | +1.02 |
Target Global Acquisition I A | TGAA | Oct 31, 2024 | 11.26 | 0.00 |
Target Global Acquisition I Unit | TGAAU | Oct 31, 2024 | 11.28 | 0.00 |
Target Hospitality | TH | Oct 31, 2024 | 7.46 | -0.40 |
Tarsus Pharmaceuticals | TARS | Oct 31, 2024 | 44.49 | -0.54 |
Taseko Mines | TGB | Oct 31, 2024 | 2.23 | -3.88 |
TaskUs A | TASK | Oct 31, 2024 | 12.64 | +1.77 |
TAT Technologies | TATT | Oct 31, 2024 | 18.23 | -3.98 |
Taylor Devices | TAYD | Oct 31, 2024 | 47.02 | -3.35 |
Taylor Morrison Home | TMHC | Oct 31, 2024 | 68.50 | -1.33 |
Taysha Gene Therapies | TSHA | Oct 31, 2024 | 1.69 | -9.63 |
TC Bancshares | TCBC | Oct 31, 2024 | 13.10 | 0.00 |
TC Biopharm ADR | TCBP | Oct 31, 2024 | 1.32 | -0.75 |
TC Energy | TRP | Oct 31, 2024 | 46.51 | +0.09 |
TCTM Kids IT Education ADR | TCTM | Oct 31, 2024 | 0.99 | -9.92 |
TCW Strategic | TSI | Oct 31, 2024 | 5.00 | -0.60 |
TD Synnex | SNX | Oct 31, 2024 | 115.35 | -3.17 |
TDH Holdings | PETZ | Oct 31, 2024 | 1.28 | -0.04 |
TE Connectivity | TEL | Oct 31, 2024 | 147.42 | -2.88 |
Team | TISI | Oct 31, 2024 | 19.81 | -0.60 |
TechnipFMC Plc | FTI | Oct 31, 2024 | 26.69 | +2.30 |
Technology & Telecommunication Acquisition A | TETE | Oct 31, 2024 | 12.16 | -0.33 |
Technology Alphadex First Trust | FXL | Oct 31, 2024 | 139.51 | -1.94 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.